Inventor · disambiguated record
Steven John Taylor
Also filed as: TAYLOR STEVEN · TAYLOR STEVEN J · TAYLOR STEVEN JOHN · TAYLOR STEVEN W
15 granted patents·26 pending applications·35 citations·filing 2001–2025
88Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS V INC13ABEYWARDANE ASITHA4SENDA BIOSCIENCES INC4EVOTEC AG2MEDIVIR AB2
Top patents by PatentIndex Score
41 records- 0190US10953027B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Mar 23, 2021·3 cites·9 claims
- 0278US8697713B2Pyrrolopyrimidines for pharmaceutical compositionsJÄKEL STEFAN·Filed 2007·Granted Apr 15, 2014·11 cites·16 claims
- 0376US8785489B2Heteroaryl substituted indole compounds useful as MMP-13 inhibitorsABEYWARDANE ASITHA·Filed 2009·Granted Jul 22, 2014·4 cites·11 claims
- 0475US8071607B2Mnk1 or Mnk2 inhibitorsCOULTER THOMAS STEPHEN·Filed 2005·Granted Dec 6, 2011·10 cites·19 claims
- 0574US2024180941A1Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0672US12115178B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0771US8633201B2Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositionsAICHER BABETTE·Filed 2007·Granted Jan 21, 2014·4 cites·12 claims
- 0870US9150556B2Benzimidazolone chymase inhibitorsABEYWARDANE ASITHA·Filed 2008·Granted Oct 6, 2015·1 cites·2 claims
- 0969US2023293458A1Multibiotic agents and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 1068US11813272B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Nov 14, 2023·0 cites·9 claims
- 1168US8637550B2Heteroaryl diamide compounds useful as MMP-13 inhibitorsFARROW NEIL ALEXANDER·Filed 2009·Granted Jan 28, 2014·2 cites·9 claims
- 1266US2024398966A1Conjugates and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 1365US11058698B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Jul 13, 2021·0 cites·2 claims
- 1464US2021283157A1Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1561US11998610B2Conjugates and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Jun 4, 2024·0 cites·2 claims
- 1661US2020101030A1Multibiotic agents and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 1759US2025295624A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 1859US2021299079A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1957US2025162990A1Compounds and methods for inhibiting cancers over-expressing replication factor c 40RAADYSAN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2053US8969348B2Chymase inhibitorsABEYWARDANE ASITHA·Filed 2009·Granted Mar 3, 2015·0 cites·3 claims
- 2153US2004229915A1Cysteine protease inhibitorsMEDIVIR AB·Filed 2004·Application pending·0 cites
- 2251US2021085640A1Acylated catechin polyphenols and methods of their use for the treatment of cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 2351US2005070598A1Cysteine protease inhibitorsMEDIVIR AB·Filed 2003·Application pending·0 cites
- 2450US2005020588A1Cysteine protease inhibitorsFiled 2004·Application pending·0 cites
- 2548US2023234917A1Asparagine derivatives and methods of using sameSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2647US2003186962A1Cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 2747US2023234967A1Fused Azole Heterocycles as AHR AntagonistsSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2846US12162902B2Decarboxylase inhibitors for treating Parkinson's diseaseSAIL BIOMEDICINES·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 2945US2009111791A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3044US2003203900A1Cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 3144US2023295152A1Pyridopyrimidinone derivatives as ahr antagonistsSENDA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3243US2008280904A1N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase InhibitorsELDRUP ANNE BETTINA·Filed 2006·Application pending·0 cites
- 3343US2023181493A1Biomarkers related to parkinson's disease and methods of using the sameSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3443US2006276515A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameCYWIN CHARLES L·Filed 2006·Application pending·0 cites
- 3542US9403830B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Aug 2, 2016·0 cites·15 claims
- 3642US2010234377A1Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthaseEVOTEC AG·Filed 2008·Application pending·0 cites
- 3741US2009069323A111beta-hsdi inhibitorsEVOTEC AG·Filed 2005·Application pending·0 cites
- 3841US2006172990A1Antibacterial agentsEAST STEPHEN P·Filed 2003·Application pending·0 cites
- 3939US2004101874A1Targets for therapeutic intervention identified in the mitochondrial proteomeMITOKOR INC·Filed 2003·Application pending·0 cites
- 4035US9139567B2Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolaseHEIM-RIETHER ALEXANDER·Filed 2012·Granted Sep 22, 2015·0 cites·19 claims
- 4134US2010143341A1Thienopyrimidines for pharmaceutical compositionsDEVELOGEN AG·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven John Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →